1. Acuna R, Martinez-de-la-Maza L, Ponce-Coria J, Vazquez N, Ortal-Vite P, Pacheco-Alvarez D, Bobadilla NA, Gamba G (2011) Rare mutations in SLC12A1 and SLC12A3 protect against hypertension by reducing the activity of renal salt cotransporters. J Hypertens 29(3):475–483. doi: 10.1097/HJH.0b013e328341d0fd
2. Arroyo JP, Lagnaz D, Ronzaud C, Vazquez N, Ko BS, Moddes L, Ruffieux-Daidie D, Hausel P, Koesters R, Yang B, Stokes JB, Hoover RS, Gamba G, Staub O (2011) Nedd4-2 modulates renal Na+-Cl− cotransporter via the aldosterone-SGK1-Nedd4-2 pathway. J Am Soc Nephrol 22(9):1707–1719. doi: 10.1681/ASN.2011020132
3. Atlas SA (2007) The renin-angiotensin aldosterone system: pathophysiological role and pharmacologic inhibition. J Manag Care Pharm 13(8 Suppl B):9–20
4. Bickel CA, Verbalis JG, Knepper MA, Ecelbarger CA (2001) Increased renal Na-K-ATPase, NCC, and beta-ENaC abundance in obese Zucker rats. Am J Physiol Renal Physiol 281(4):F639–648
5. Bostanjoglo M, Reeves WB, Reilly RF, Velazquez H, Robertson N, Litwack G, Morsing P, Dorup J, Bachmann S, Ellison DH (1998) 11Beta-hydroxysteroid dehydrogenase, mineralocorticoid receptor, and thiazide-sensitive Na-Cl cotransporter expression by distal tubules. J Am Soc Nephrol 9(8):1347–1358